跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 114 条关于
“CA10”
全部
114
临床试验
51
药物
47
机构
0
资讯
16
去年
Sinovac Launches Phase III Trial of Bivalent HFMD Vaccine
去年
Cantargia Expands CAN10 Development to Target Treatment-Resistant Atopic Dermatitis
去年
Cantargia's CAN10 Shows Promising Phase 1 Results for Hidradenitis Suppurativa Treatment
去年
Cantargia Expands Phase I Trial of CAN10 Antibody for Inflammatory Diseases
去年
Allterum Therapeutics Receives FDA Clearance for 4A10 Antibody Therapy in Pediatric Leukemia
去年
GBI Biomanufacturing and Allterum Therapeutics Partner to Advance 4A10 into Clinical Trials
去年
Cantargia's CAN10 Demonstrates Promising Biomarker Results and Safety in Phase 1 Trial
去年
Cantargia Advances Nadunolimab Development Following TRIFOUR Trial Results, Secures Otsuka Partnership for CAN10 Program
去年
Anivive Completes Pivotal Field Trial for Canine Lymphoma Drug Laverdia-CA1
去年
Canalevia-CA1 Receives FDA Renewal for Chemotherapy-Induced Diarrhea in Dogs
第 1 页,共 2 页
上一页
下一页